Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
St. Jude Children's Research Hospital
AbbVie
The Hospital for Sick Children
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Societe Internationale d'Oncologie Pediatrique
Children's Oncology Group
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
City of Hope Medical Center
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
NYU Langone Health
NYU Langone Health
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Universitätsklinikum Hamburg-Eppendorf
National Cancer Institute (NCI)
University of Pittsburgh
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fox Chase Cancer Center
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
NYU Langone Health
NYU Langone Health
Duke University